Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(2)

DRUG(2)

DEVICE(1)

0.9% sodium chloride solution

medical-university-of-vienna

Unfractionated heparin

1 trial

phase_2_3

medical-university-of-vienna

Change of blood flow or sweep gas flow ( ILA Activve)

1 trial

not_applicable

medical-university-of-vienna

5 unique interventions3 categories

Analytics

Trial Phases

Phase 22

Phase 31

Trial Status

Completed1

Terminated1

Other1

Role Distribution

Principal Investigator3

PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05226442Phase 2/3Completed

Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO

Anticoagulants and Bleeding DisordersExtracorporeal Membrane Oxygenation Complication

PrincipalinvestigatorStart date: 2021-12-01

NCT02895373Phase 2Terminated

PGE1 as Additive Anticoagulant in ECMO-Therapy

Extracorporeal Membrane OxygenationRespiratory Distress Syndrome, Adult

PrincipalinvestigatorStart date: 2016-07-01

NCT01997528Not ApplicableUnknown

Gas Transfer on ILA-Activve

Hypercapnia

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Anticoagulants and Bleeding Disorders1 Extracorporeal Membrane Oxygenation1 Extracorporeal Membrane Oxygenation Complication1 Hypercapnia1 Respiratory Distress Syndrome, Adult1

Affiliations

Medical University of Vienna

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Eddy Fan, MD, PhD

University Health Network, Toronto

5 trials

Shared therapeutic areas:

Extracorporeal Membrane Oxygenation ComplicationRespiratory Distress Syndrome, Adult

Similarity Score12%

Marc Moss, MD

University of Colorado, Denver

8 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Roy Brower, MD

Johns Hopkins University

2 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Gregory A. Schmidt, MD, FCCP

University of Chicago

1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Arthur Wheeler, MD

Vanderbilt University

1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Herbert Wiedemann, MD

Cleveland Clinic Lerner College of Medicine

1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Robert D. Hite, MD

Wake Forest University Health Sciences

1 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

David A. Schoenfeld, PhD

Massachusetts General Hospital

2 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Joaquim MATEO, MD

Assistance Publique - Hôpitaux de Paris

10 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Marcus J Schultz, MD, PhD

Department of Intensive Care, Academic Medical Center, University of Amsterdam

4 trials

Shared therapeutic areas:

Respiratory Distress Syndrome, Adult

Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05226442Phase 2/3PrincipalInvestigator

Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO

Anticoagulants and Bleeding DisordersExtracorporeal Membrane Oxygenation Complication

Completed

NCT02895373Phase 2PrincipalInvestigator

PGE1 as Additive Anticoagulant in ECMO-Therapy

Extracorporeal Membrane OxygenationRespiratory Distress Syndrome, Adult

Terminated

NCT01997528Not ApplicablePrincipalInvestigator

Gas Transfer on ILA-Activve

Hypercapnia

Unknown

All 3 trials loaded